Dosage Forms

Articles

The technology, known as Verifi, is available with the ChargePoint’s range of valves that ensure safe and contamination-free handling of API and other formulation ingredients.

ChargePoint Technology Launches Smart Monitoring Technology at Achema 2018

Unlike current approaches where bioconjugation is typically done following the manufacture of the monoclonal antibody and the cytotoxic drug, the new method begins with the antibody supernatants and eliminates the need for extensive chromatographic purification. 

ADC Bio to Develop New Bioconjugation Process

Cambrex invests in development and laboratory facilities and adds staff.

Cambrex Expands API Development at Iowa Facility

Hovione has installed a new MG2 Tekna Precision Capsule filler at its Portugal site.

Hovione Adds New Capsule Filler at Portugal Site

Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.

CDMOs have established strategies for handling new chemical entities with unknown biological activity.

Managing Potentially Potent APIs

Cambrex is investing $24 Million in new, highly potent API manufacturing capacity at its Charles City, Iowa site.

Cambrex Adds HPAPI Capacity

CordenPharma is investing €10 Million in a new line at its Plankstadt, Germany site.

CordenPharma Adds Manufacturing Line for Vet Drug Products

ChargePoint Technology is expanding its US presence by opening a new office in San Francisco. 

ChargePoint Adds US Office

The Spanish CDMO has installed a new automatic capsule filling machine at its EU GMP-approved plant in Pamplona, Spain

Idifarma Expands Capsule Filling Capabilities

Takeda will build a new production facility at its existing Grange Castle site in Ireland.

Highly Potent Drugs